Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome

Chinese Journal of Integrative Medicine

Volumn 17, Issue 9, 2011, Pages 710-714

  Wu, Guo Lin ^a   Li, Tian Yi ^b   Fan, Yong Sheng ^b   Yu, Guo You ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Chinese herbal medicine; Nourishing yin; Primary Sjogren's syndrome; Quality of life; Removing stasis; Strengthening qi

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; OSTEOPONTIN; UNCLASSIFIED DRUG; YIQI YANGYIN QUYU DECOCTION;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SJOEGREN SYNDROME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD SEDIMENTATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; OSTEOPONTIN; QI; QUALITY OF LIFE; QUESTIONNAIRES; SJOGREN'S SYNDROME; YIN-YANG; YOUNG ADULT;

EID: 84874669044     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0850-8     Document Type: Article

References (12)

1. Zhao Y, Dong Y. The clinical picture of primary Sjogren's syndrome. Beijing Med (Chin) 1997;19:100-104.
2. Chiocchetti A, Indelicato M, Bensi T, Mesturini R, Giordano M, Sametti S, et al. High levels of osteopontin with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 2004;103:1376-1382.
3. Zhao Y, Fei YY, Deng XX, Zhang PL, Gan XD, Shi YP, et al. Significance of anti-ot-fodrin antibody in the diagnosis of Sjoegren's syndrome and its correlation with clinical manifestations. Chin J Rheumatol (Chin) 2005;9:261-264.
4. Wu GL, Han YM, Fan YS, Yu GY. Effects of Chinese herbal medicine for Yiqi Yangyin Quyu in treating Sjoegren's syndrome and on patients immunologic function. Chin J Integr Tradit West Med (Chin) 2006;26:322-324.
5. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.
6. Wan CH, Fang JQ, Tang XL, Zhang CZ, Lu YB, Meng Q, et al. The effect evaluation on measuring quality of life in patients with liver cancer by SF-36 scale. Tumor (Chin) 2005;25:492-494.
7. Dawson LJ, Caulfield VL, Stanbury JB, Field AE, Christmas SE, Smith PM. Hydroxy chloroquine therapy in patients with primary Sjsgren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford) 2005;44:449-455.
8. Blom T, Franzén A, Heinegård D, Holmdahl R. Comment on "The influence of the proinflammatory cytokine osteopontin on autoimmune demyelinating disease". Science 2003;299: 1845-1850.
9. Hummelshoj T, Ryder LP, Madsen HO, Odum N, Svejgaard A. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor SP1 and elevated gene expression. Mol Immunol 2006;43:980-986.
10. Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J Am Dent Assoc 2008;139:291-299;quiz 358-359.
11. Li XM, Duan LP, Wan CH, Zhou ZF, Pan JH, Yang Z, et al. Evaluation of SF-36 instrument with the quality of life in chronic diseases. China Med (Chin) 2006;1:645-648.
12. Ricci R, Quesada A, Pignalberi C, Roda J, Disertori M, Capucci A, et al. Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol 2004;10:85-92.